Jacobs Levy Equity Management
MBIO icon

Jacobs Levy Equity Management’s Mustang Bio MBIO Stock Holding History

Jacobs Levy Equity Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63
Closed -$157K – 1094
2021
Q2 		$157K Sell
63
-1,305
-95% -$3.2M ﹤0.01% 999
2021
Q1 		$3.41M Sell
1,368
-39
-3% -$116K 0.03% 503
2020
Q4 		$3.99M Buy
1,407
+627
+80% +$1.5M 0.04% 435
2020
Q3 		$1.84M Buy
780
+562
+258% +$1.39M 0.02% 534
2020
Q2 		$520K Buy
+218
New +$510K 0.01% 780

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jacobs Levy Equity Management's MBIO Position: Q3 2021 in Review

Jacobs Levy Equity Management sold out of Mustang Bio (MBIO) in Q3 2021, closing a stake of 63 shares — an estimated $157K sold.

Jacobs Levy Equity Management first reported a position in MBIO in Q2 2020 and held it in 5 quarters. The position peaked at $3.99M in Q4 2020. 79 funds tracked by Wall St. Rank hold MBIO as of Q3 2021.

  • Jacobs Levy Equity Management reported no remaining Mustang Bio position as of Q3 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 63 Mustang Bio shares in Q3 2021, an estimated $157K.
  • Jacobs Levy Equity Management first reported a position in Mustang Bio in Q2 2020 and held it in 5 quarters.
  • Jacobs Levy Equity Management's Mustang Bio position peaked at $3.99M in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Mustang Bio as of Q3 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2021, filed 15 Nov 2021.